{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:19:23Z","timestamp":1786979963300,"version":"build-2736575974"},"reference-count":105,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2010,4,14]],"date-time":"2010-04-14T00:00:00Z","timestamp":1271203200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2011,2]]},"DOI":"10.1007\/s00296-010-1446-x","type":"journal-article","created":{"date-parts":[[2010,4,13]],"date-time":"2010-04-13T02:15:34Z","timestamp":1271124934000},"page":"153-164","source":"Crossref","is-referenced-by-count":122,"title":["Platelet function in rheumatoid arthritis: arthritic and cardiovascular implications"],"prefix":"10.1007","volume":"31","author":[{"given":"Armen Yuri","family":"Gasparyan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonios","family":"Stavropoulos-Kalinoglou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitri P.","family":"Mikhailidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen M. J.","family":"Douglas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George D.","family":"Kitas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,4,14]]},"reference":[{"key":"1446_CR1","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.semarthrit.2006.08.006","volume":"36","author":"Y Alamanos","year":"2006","unstructured":"Alamanos Y, Voulgari PV, Drosos AA (2006) Incidence and prevalence of rheumatoid arthritis, based on the 1987 American College of Rheumatology criteria: a systematic review. Semin Arthritis Rheum 36:182\u2013188","journal-title":"Semin Arthritis Rheum"},{"issue":"10 Suppl 1","key":"1446_CR2","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1016\/j.amjmed.2008.06.011","volume":"121","author":"SE Gabriel","year":"2008","unstructured":"Gabriel SE (2008) Cardiovascular morbidity and mortality in rheumatoid arthritis. Am J Med 121(10 Suppl 1):S9\u2013S14","journal-title":"Am J Med"},{"key":"1446_CR3","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1002\/art.10089","volume":"46","author":"S Doornum Van","year":"2002","unstructured":"Van Doornum S, McColl G, Wicks IP (2002) Accelerated atherosclerosis: an extraarticular feature of rheumatoid arthritis? Arthritis Rheum 46:862\u2013873","journal-title":"Arthritis Rheum"},{"issue":"6A","key":"1446_CR4","doi-asserted-by":"crossref","first-page":"33D","DOI":"10.1016\/S0002-9149(02)02235-X","volume":"89","author":"AN DeMaria","year":"2002","unstructured":"DeMaria AN (2002) Relative risk of cardiovascular events in patients with rheumatoid arthritis. Am J Cardiol 89(6A):33D\u201338D","journal-title":"Am J Cardiol"},{"key":"1446_CR5","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1093\/rheumatology\/keg175","volume":"42","author":"GD Kitas","year":"2003","unstructured":"Kitas GD, Erb N (2003) Tackling ischaemic heart disease in rheumatoid arthritis. Rheumatology (Oxford) 42:607\u2013613","journal-title":"Rheumatology (Oxford)"},{"key":"1446_CR6","doi-asserted-by":"crossref","unstructured":"Gasparyan AY, Stavropoulos-Kalinoglou A, Mikhailidis DP, Toms TE, Douglas KM, Kitas GD (2010) The rationale for comparative studies of accelerated atherosclerosis in rheumatic diseases. Curr Vasc Pharmacol (In press)","DOI":"10.2174\/1570210197581141611"},{"key":"1446_CR7","first-page":"36","volume":"30","author":"F Wolfe","year":"2003","unstructured":"Wolfe F, Freundlich B, Straus WL (2003) Increase in cardiovascular and cerebrovascular disease prevalence in rheumatoid arthritis. J Rheumatol 30:36\u201340","journal-title":"J Rheumatol"},{"key":"1446_CR8","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1002\/art.21560","volume":"54","author":"PJ Nicola","year":"2006","unstructured":"Nicola PJ, Crowson CS, Maradit-Kremers H, Ballman KV, Roger VL, Jacobsen SJ, Gabriel SE (2006) Contribution of congestive heart failure and ischemic heart disease to excess mortality in rheumatoid arthritis. Arthritis Rheum 54:60\u201367","journal-title":"Arthritis Rheum"},{"key":"1446_CR9","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1016\/S0735-1097(99)00033-9","volume":"33","author":"GY Lip","year":"1999","unstructured":"Lip GY, Gibbs CR (1999) Does heart failure confer a hypercoagulable state? Virchow\u2019s triad revisited. J Am Coll Cardiol 33:1424\u20131426","journal-title":"J Am Coll Cardiol"},{"key":"1446_CR10","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1097\/HCO.0b013e3282fcd64d","volume":"23","author":"AM Ahnert","year":"2008","unstructured":"Ahnert AM, Freudenberger RS (2008) What do we know about anticoagulation in patients with heart failure? Curr Opin Cardiol 23:228\u2013232","journal-title":"Curr Opin Cardiol"},{"key":"1446_CR11","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1002\/1529-0131(200112)44:12<2737::AID-ART460>3.0.CO;2-#","volume":"44","author":"ID del Rinc\u00f3n","year":"2001","unstructured":"del Rinc\u00f3n ID, Williams K, Stern MP, Freeman GL, Escalante A (2001) High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors. Arthritis Rheum 44:2737\u20132745","journal-title":"Arthritis Rheum"},{"key":"1446_CR12","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1186\/ar2515","volume":"10","author":"Z Szekanecz","year":"2008","unstructured":"Szekanecz Z, Koch AE (2008) Vascular involvement in rheumatic diseases: \u2018vascular rheumatology\u2019. Arthritis Res Ther 10:224","journal-title":"Arthritis Res Ther"},{"key":"1446_CR13","doi-asserted-by":"crossref","first-page":"2957","DOI":"10.1161\/01.CIR.0000099844.31524.05","volume":"108","author":"N Sattar","year":"2003","unstructured":"Sattar N, McCarey DW, Capell H, McInnes IB (2003) Explaining how \u201chigh-grade\u201d systemic inflammation accelerates vascular risk in rheumatoid arthritis. Circulation 108:2957\u20132963","journal-title":"Circulation"},{"key":"1446_CR14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S1462399405009154","volume":"7","author":"RJ Stevens","year":"2005","unstructured":"Stevens RJ, Douglas KM, Saratzis AN, Kitas GD (2005) Inflammation and atherosclerosis in rheumatoid arthritis. Expert Rev Mol Med 7:1\u201324","journal-title":"Expert Rev Mol Med"},{"key":"1446_CR15","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/S1568-9972(02)00100-3","volume":"1","author":"PA Bacon","year":"2002","unstructured":"Bacon PA, Stevens RJ, Carruthers DM, Young SP, Kitas GD (2002) Accelerated atherogenesis in autoimmune rheumatic diseases. Autoimmun Rev 1:338\u2013347","journal-title":"Autoimmun Rev"},{"key":"1446_CR16","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1093\/rheumatology\/ken395","volume":"48","author":"F Montecucco","year":"2009","unstructured":"Montecucco F, Mach F (2009) Common inflammatory mediators orchestrate pathophysiological processes in rheumatoid arthritis and atherosclerosis. Rheumatology (Oxford) 48:11\u201322","journal-title":"Rheumatology (Oxford)"},{"key":"1446_CR17","doi-asserted-by":"crossref","first-page":"431","DOI":"10.3109\/00313028609087564","volume":"18","author":"DG Palmer","year":"1986","unstructured":"Palmer DG, Hogg N, Revell PA (1986) Lymphocytes, polymorphonuclear leukocytes, macrophages and platelets in synovium involved by rheumatoid arthritis. A study with monoclonal antibodies. Pathology 18:431\u2013437","journal-title":"Pathology"},{"key":"1446_CR18","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/BF00683878","volume":"4","author":"M Farr","year":"1984","unstructured":"Farr M, Wainwright A, Salmon M, Hollywell CA, Bacon PA (1984) Platelets in the synovial fluid of patients with rheumatoid arthritis. Rheumatol Int 4:13\u201317","journal-title":"Rheumatol Int"},{"key":"1446_CR19","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/BF00270285","volume":"9","author":"GK Endresen","year":"1989","unstructured":"Endresen GK (1989) Evidence for activation of platelets in the synovial fluid from patients with rheumatoid arthritis. Rheumatol Int 9:19\u201324","journal-title":"Rheumatol Int"},{"key":"1446_CR20","first-page":"181","volume":"10","author":"GK Endresen","year":"1992","unstructured":"Endresen GK, F\u00f8rre O (1992) Human platelets in synovial fluid. A focus on the effects of growth factors on the inflammatory responses in rheumatoid arthritis. Clin Exp Rheumatol 10:181\u2013187","journal-title":"Clin Exp Rheumatol"},{"key":"1446_CR21","doi-asserted-by":"crossref","first-page":"204","DOI":"10.3109\/03009748109095299","volume":"10","author":"GK Endresen","year":"1981","unstructured":"Endresen GK (1981) Investigation of blood platelets in synovial fluid from patients with rheumatoid arthritis. Scand J Rheumatol 10:204\u2013208","journal-title":"Scand J Rheumatol"},{"key":"1446_CR22","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1093\/rheumatology\/keh638","volume":"44","author":"M Schmitt-Sody","year":"2005","unstructured":"Schmitt-Sody M, Klose A, Gottschalk O, Metz P, Gebhard H, Zysk S, Eichhorn ME, Hernandez-Richter TM, Jansson V, Veihelmann A (2005) Platelet\u2013endothelial cell interactions in murine antigen-induced arthritis. Rheumatology (Oxford) 44:885\u2013889","journal-title":"Rheumatology (Oxford)"},{"key":"1446_CR23","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1080\/09537100701191315","volume":"18","author":"M Schmitt-Sody","year":"2007","unstructured":"Schmitt-Sody M, Metz P, Gottschalk O, Birkenmaier C, Zysk S, Veihelmann A, Jansson V (2007) Platelet P-selectin is significantly involved in leukocyte-endothelial cell interaction in murine antigen-induced arthritis. Platelets 18:365\u2013372","journal-title":"Platelets"},{"key":"1446_CR24","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1080\/03009740701218741","volume":"36","author":"M Schmitt-Sody","year":"2007","unstructured":"Schmitt-Sody M, Metz P, Klose A, Gottschalk O, Zysk S, Hausdorf J, Veihelmann A, Jansson V (2007) In vivo interactions of platelets and leucocytes with the endothelium in murine antigen-induced arthritis: the role of P-selectin. Scand J Rheumatol 36:311\u2013319","journal-title":"Scand J Rheumatol"},{"key":"1446_CR25","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s002960000067","volume":"20","author":"Y Waguri-Nagaya","year":"2000","unstructured":"Waguri-Nagaya Y, Otsuka T, Sugimura I, Matsui N, Asai K, Nakajima K, Tada T, Akiyama S, Kato T (2000) Synovial inflammation and hyperplasia induced by gliostatin\/platelet-derived endothelial cell growth factor in rabbit knees. Rheumatol Int 20:13\u201319","journal-title":"Rheumatol Int"},{"key":"1446_CR26","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1002\/art.1780230705","volume":"23","author":"C Shapleigh","year":"1980","unstructured":"Shapleigh C, Valone FH, Schur PH, Goetzl EJ, Austen KF (1980) Platelet-activating activity in synovial fluids of patients with rheumatoid arthritis, juvenile rheumatoid arthritis, gout, and noninflammatory arthropathies. Arthritis Rheum 23:800\u2013807","journal-title":"Arthritis Rheum"},{"key":"1446_CR27","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/BF00541248","volume":"2","author":"E Weissbarth","year":"1982","unstructured":"Weissbarth E, Baruth B, Mielke H, Liman W, Deicher H (1982) Platelets as target cells in rheumatoid arthritis and systemic lupus erythematosus: a platelet specific immunoglobulin inducing the release reaction. Rheumatol Int 2:67\u201373","journal-title":"Rheumatol Int"},{"key":"1446_CR28","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.2174\/138161207780831383","volume":"13","author":"IA Jagroop","year":"2007","unstructured":"Jagroop IA, Kakafika AI, Mikhailidis DP (2007) Platelets and vascular risk: an option for treatment. Curr Pharm Des 13:1669\u20131683","journal-title":"Curr Pharm Des"},{"key":"1446_CR29","doi-asserted-by":"crossref","first-page":"3339","DOI":"10.1172\/JCI26674","volume":"115","author":"K Kaushansky","year":"2005","unstructured":"Kaushansky K (2005) The molecular mechanisms that control thrombopoiesis. J Clin Invest 115:3339\u20133347","journal-title":"J Clin Invest"},{"key":"1446_CR30","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1080\/09537100801990582","volume":"19","author":"P Harrison","year":"2008","unstructured":"Harrison P, Goodall AH (2008) \u201cMessage in the platelet\u201d\u2014more than just vestigial mRNA! Platelets 19:395\u2013404","journal-title":"Platelets"},{"key":"1446_CR31","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1160\/TH08-03-0186","volume":"101","author":"E Lerkevang Grove","year":"2009","unstructured":"Lerkevang Grove E, Hvas AM, Dalby Kristensen S (2009) Immature platelets in patients with acute coronary syndromes. Thromb Haemost 101:151\u2013156","journal-title":"Thromb Haemost"},{"key":"1446_CR32","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1056\/NEJMra071014","volume":"357","author":"G Dav\u00ec","year":"2007","unstructured":"Dav\u00ec G, Patrono C (2007) Platelet activation and atherothrombosis. N Engl J Med 357:2482\u20132494","journal-title":"N Engl J Med"},{"key":"1446_CR33","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1080\/09537100701210057","volume":"19","author":"GE Pamuk","year":"2008","unstructured":"Pamuk GE, Vural O, Turgut B, Demir M, Pamuk ON, Cakir N (2008) Increased platelet activation markers in rheumatoid arthritis: are they related with subclinical atherosclerosis? Platelets 19:146\u2013154","journal-title":"Platelets"},{"key":"1446_CR34","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1160\/TH08-05-0336","volume":"100","author":"E Yetkin","year":"2008","unstructured":"Yetkin E (2008) Mean platelet volume not so far from being a routine diagnostic and prognostic measurement. Thromb Haemost 100:3\u20134","journal-title":"Thromb Haemost"},{"key":"1446_CR35","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1097\/00001721-199603000-00011","volume":"7","author":"PM Bath","year":"1996","unstructured":"Bath PM, Butterworth RJ (1996) Platelet size: measurement, physiology and vascular disease. Blood Coagul Fibrinolysis 7:157\u2013161","journal-title":"Blood Coagul Fibrinolysis"},{"key":"1446_CR36","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.thromres.2006.09.002","volume":"120","author":"CJ Boos","year":"2007","unstructured":"Boos CJ, Lip GY (2007) Assessment of mean platelet volume in coronary artery disease\u2014what does it mean? Thromb Res 120:11\u201313","journal-title":"Thromb Res"},{"key":"1446_CR37","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1080\/09537100075760","volume":"11","author":"IA Jagroop","year":"2000","unstructured":"Jagroop IA, Clatworthy I, Lewin J, Mikhailidis DP (2000) Shape change in human platelets: measurement with a channelyzer and visualisation by electron microscopy. Platelets 11:28\u201332","journal-title":"Platelets"},{"key":"1446_CR38","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1111\/j.1751-553X.2007.00885.x","volume":"29","author":"K Javela","year":"2007","unstructured":"Javela K, Kekom\u00e4ki R (2007) Mean platelet size related to glycoprotein-specific autoantibodies and platelet-associated IgG. Int J Lab Hematol 29:433\u2013441","journal-title":"Int J Lab Hematol"},{"key":"1446_CR39","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1177\/107602960300900301","volume":"9","author":"S Tsiara","year":"2003","unstructured":"Tsiara S, Elisaf M, Jagroop IA, Mikhailidis DP (2003) Platelets as predictors of vascular risk: is there a practical index of platelet activity? Clin Appl Thromb Hemost 9:177\u2013190","journal-title":"Clin Appl Thromb Hemost"},{"key":"1446_CR40","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1080\/09537100600800412","volume":"18","author":"G Avramakis","year":"2007","unstructured":"Avramakis G, Papadimitraki E, Papakonstandinou D, Liakou K, Zidianakis M, Dermitzakis A, Mikhailidis DP, Ganotakis ES (2007) Platelets and white blood cell subpopulations among patients with myocardial infarction and unstable angina. Platelets 18:16\u201323","journal-title":"Platelets"},{"key":"1446_CR41","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1160\/TH07-12-0712","volume":"99","author":"A Muscari","year":"2008","unstructured":"Muscari A, De Pascalis S, Cenni A, Ludovico C, Castaldini N, Antonelli S, Bianchi G, Magalotti D, Zoli M (2008) Determinants of mean platelet volume (MPV) in an elderly population: relevance of body fat, blood glucose and ischaemic electrocardiographic changes. Thromb Haemost 99:1079\u20131084","journal-title":"Thromb Haemost"},{"key":"1446_CR42","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1097\/MBC.0b013e3283049697","volume":"19","author":"Y Colkesen","year":"2008","unstructured":"Colkesen Y, Acil T, Abayli B, Yigit F, Katircibasi T, Kocum T, Demircan S, Sezgin A, Ozin B, Muderrisoglu H (2008) Mean platelet volume is elevated during paroxysmal atrial fibrillation: a marker of increased platelet activation? Blood Coagul Fibrinolysis 19:411\u2013414","journal-title":"Blood Coagul Fibrinolysis"},{"key":"1446_CR43","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1046\/j.1365-2141.2002.03441.x","volume":"117","author":"G Endler","year":"2002","unstructured":"Endler G, Klimesch A, Sunder-Plassmann H, Schillinger M, Exner M, Mannhalter C, Jordanova N, Christ G, Thalhammer R, Huber K, Sunder-Plassmann R (2002) Mean platelet volume is an independent risk factor for myocardial infarction but not for coronary artery disease. Br J Haematol 117:399\u2013404","journal-title":"Br J Haematol"},{"key":"1446_CR44","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1016\/0140-6736(91)92719-I","volume":"338","author":"JF Martin","year":"1991","unstructured":"Martin JF, Bath PM, Burr ML (1991) Influence of platelet size on outcome after myocardial infarction. Lancet 338:1409\u20131411","journal-title":"Lancet"},{"key":"1446_CR45","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1161\/01.STR.0000116105.26237.EC","volume":"35","author":"P Bath","year":"2004","unstructured":"Bath P, Algert C, Chapman N, Neal B (2004) PROGRESS Collaborative Group. Association of mean platelet volume with risk of stroke among 3134 individuals with history of cerebrovascular disease. Stroke 35:622\u2013626","journal-title":"Stroke"},{"key":"1446_CR46","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1080\/09537100802187121","volume":"19","author":"E Coban","year":"2008","unstructured":"Coban E, Adanir H (2008) Platelet activation in patients with familial Mediterranean fever. Platelets 19:405\u2013408","journal-title":"Platelets"},{"key":"1446_CR47","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.cccn.2003.12.030","volume":"343","author":"M Milovanovic","year":"2004","unstructured":"Milovanovic M, Nilsson E, J\u00e4remo P (2004) Relationships between platelets and inflammatory markers in rheumatoid arthritis. Clin Chim Acta 343:237\u2013240","journal-title":"Clin Chim Acta"},{"key":"1446_CR48","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.jbspin.2007.06.016","volume":"75","author":"B Kisacik","year":"2008","unstructured":"Kisacik B, Tufan A, Kalyoncu U, Karadag O, Akdogan A, Ozturk MA, Kiraz S, Ertenli I, Calguneri M (2008) Mean platelet volume (MPV) as an inflammatory marker in ankylosing spondylitis and rheumatoid arthritis. Joint Bone Spine 75:291\u2013294","journal-title":"Joint Bone Spine"},{"key":"1446_CR49","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s00296-003-0289-0","volume":"23","author":"I Ertenli","year":"2003","unstructured":"Ertenli I, Kiraz S, Ozt\u00fcrk MA, Haznedaro\u011flu I, Celik I, Calg\u00fcneri M (2003) Pathologic thrombopoiesis of rheumatoid arthritis. Rheumatol Int 23:49\u201360","journal-title":"Rheumatol Int"},{"key":"1446_CR50","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1136\/ard.42.5.545","volume":"42","author":"M Farr","year":"1983","unstructured":"Farr M, Scott DL, Constable TJ, Hawker RJ, Hawkins CF, Stuart J (1983) Thrombocytosis of active rheumatoid disease. Ann Rheum Dis 42:545\u2013549","journal-title":"Ann Rheum Dis"},{"key":"1446_CR51","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1111\/j.1572-0241.2001.03621.x","volume":"96","author":"AN Kapsoritakis","year":"2001","unstructured":"Kapsoritakis AN, Koukourakis MI, Sfiridaki A, Potamianos SP, Kosmadaki MG, Koutroubakis IE, Kouroumalis EA (2001) Mean platelet volume: a useful marker of inflammatory bowel disease activity. Am J Gastroenterol 96:776\u2013781","journal-title":"Am J Gastroenterol"},{"key":"1446_CR52","first-page":"202","volume":"13","author":"MA Barradas","year":"1994","unstructured":"Barradas MA, Stansby G, Hamilton G, Mikhailidis DP (1994) Diminished platelet yield and enhanced platelet aggregability in platelet-rich plasma of peripheral vascular disease patients. Int Angiol 13:202\u2013207","journal-title":"Int Angiol"},{"key":"1446_CR53","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1002\/art.1780220814","volume":"22","author":"PC Fink","year":"1979","unstructured":"Fink PC, Piening U, Fricke PM, Deicher H (1979) Platelet aggregation and aggregation inhibition by different antiglobulins and antiglobulin complexes from sera of patients with rheumatoid arthritis. Arthritis Rheum 22:896\u2013903","journal-title":"Arthritis Rheum"},{"key":"1446_CR54","first-page":"69","volume":"111","author":"SA Saeed","year":"2002","unstructured":"Saeed SA, Gilani AH, Rasheed H, Bhatti FN, Atiq M, Qureshi A, Jafary R, Connor JD (2002) Plasma from rheumatoid patients taking low dose methotrexate enhances platelet aggregation. Res Commun Mol Pathol Pharmacol 111:69\u201376","journal-title":"Res Commun Mol Pathol Pharmacol"},{"key":"1446_CR55","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1093\/rheumatology\/41.4.458","volume":"41","author":"EA Knijff-Dutmer","year":"2002","unstructured":"Knijff-Dutmer EA, Kalsbeek-Batenburg EM, Koerts J, van de Laar MA (2002) Platelet function is inhibited by non-selective non-steroidal anti-inflammatory drugs but not by cyclo-oxygenase-2-selective inhibitors in patients with rheumatoid arthritis. Rheumatology (Oxford) 41:458\u2013461","journal-title":"Rheumatology (Oxford)"},{"key":"1446_CR56","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1002\/art.1780240118","volume":"24","author":"M Alcalay","year":"1981","unstructured":"Alcalay M, Bontoux D, Peltier A, Vial MC, Vilde JM, Wautier JL (1981) C7 deficiency, abnormal platelet aggregation, and rheumatoid arthritis. Arthritis Rheum 24:102\u2013103","journal-title":"Arthritis Rheum"},{"key":"1446_CR57","first-page":"103","volume":"47","author":"A Falus","year":"1982","unstructured":"Falus A, Mer\u00e9tey K, Bagdy D, Di\u00f3szegi M, B\u00f6hm U, Cs\u00e1k E, Bozs\u00f3ky S (1982) Beta-2-microglobulin-specific autoantibodies cause platelet aggregation and interfere with ADP-induced aggregation. Clin Exp Immunol 47:103\u2013109","journal-title":"Clin Exp Immunol"},{"key":"1446_CR58","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/j.1749-6632.1981.tb29717.x","volume":"370","author":"JM Riddle","year":"1981","unstructured":"Riddle JM, Bluhm GB, Pitchford WC, McElroy H, Jimenea C, Leisen J, Venkatasubramanian K (1981) A comparative study of platelet reactivity in arthritis. Ann N Y Acad Sci 370:22\u201329","journal-title":"Ann N Y Acad Sci"},{"key":"1446_CR59","doi-asserted-by":"crossref","first-page":"139","DOI":"10.3109\/03009748209098179","volume":"11","author":"S Colli","year":"1982","unstructured":"Colli S, Maderna P, Tremoli E, Colombo F, Canesi B (1982) Platelet function in rheumatoid arthritis. Scand J Rheumatol 11:139\u2013143","journal-title":"Scand J Rheumatol"},{"key":"1446_CR60","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1093\/rheumatology\/36.2.164","volume":"36","author":"AJ Littler","year":"1997","unstructured":"Littler AJ, Buckley CD, Wordsworth P, Collins I, Martinson J, Simmons DL (1997) A distinct profile of six soluble adhesion molecules (ICAM-1, ICAM-3, VCAM-1, E-selectin, L-selectin and P-selectin) in rheumatoid arthritis. Br J Rheumatol 36:164\u2013169","journal-title":"Br J Rheumatol"},{"key":"1446_CR61","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1007\/s100670050047","volume":"18","author":"PP Sfikakis","year":"1999","unstructured":"Sfikakis PP, Charalambopoulos D, Vaiopoulos G, Mavrikakis M (1999) Circulating P- and L-selectin and T-lymphocyte activation and patients with autoimmune rheumatic diseases. Clin Rheumatol 18:28\u201332","journal-title":"Clin Rheumatol"},{"key":"1446_CR62","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s00296-007-0397-3","volume":"28","author":"MF Meyer","year":"2007","unstructured":"Meyer MF, Schmidt O, Hellmich B, Schatz H, Klein HH, Braun J (2007) Microvascular dysfunction in rheumatoid arthritis assessed by laser Doppler anemometry: relationship to soluble adhesion molecules and extraarticular manifestations. Rheumatol Int 28:145\u2013152","journal-title":"Rheumatol Int"},{"key":"1446_CR63","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1016\/S0002-9440(10)61237-0","volume":"167","author":"G Li","year":"2005","unstructured":"Li G, Sanders JM, Phan ET, Ley K, Sarembock IJ (2005) Arterial macrophages and regenerating endothelial cells express P-selectin in atherosclerosis-prone apolipoprotein E-deficient mice. Am J Pathol 167:1511\u20131518","journal-title":"Am J Pathol"},{"key":"1446_CR64","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1056\/NEJM199607043350108","volume":"335","author":"PS Frenette","year":"1996","unstructured":"Frenette PS, Wagner DD (1996) Adhesion molecules: part II. Blood vessels and blood cells. N Engl J Med 335:43\u201345","journal-title":"N Engl J Med"},{"key":"1446_CR65","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1159\/000083844","volume":"33","author":"I Chung","year":"2003","unstructured":"Chung I, Lip GY (2003) Virchow\u2019s triad revisited: blood constituents. Pathophysiol Haemost Thromb 33:449\u2013454","journal-title":"Pathophysiol Haemost Thromb"},{"key":"1446_CR66","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1161\/01.RES.0000252802.25497.b7","volume":"100","author":"P Hundelshausen von","year":"2007","unstructured":"von Hundelshausen P, Weber C (2007) Platelets as immune cells: bridging inflammation and cardiovascular disease. Circ Res 100:27\u201340","journal-title":"Circ Res"},{"key":"1446_CR67","doi-asserted-by":"crossref","first-page":"99","DOI":"10.2174\/187152908784533739","volume":"8","author":"A McNicol","year":"2008","unstructured":"McNicol A, Israels SJ (2008) Beyond hemostasis: the role of platelets in inflammation, malignancy and infection. Cardiovasc Hematol Disord Drug Targets 8:99\u2013117","journal-title":"Cardiovasc Hematol Disord Drug Targets"},{"key":"1446_CR68","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/j.1365-2249.2004.02421.x","volume":"136","author":"PF Sumariwalla","year":"2004","unstructured":"Sumariwalla PF, Malfait AM, Feldmann M (2004) P-selectin glycoprotein ligand 1 therapy ameliorates established collagen-induced arthritis in DBA\/1 mice partly through the suppression of tumour necrosis factor. Clin Exp Immunol 136:67\u201375","journal-title":"Clin Exp Immunol"},{"key":"1446_CR69","first-page":"1054","volume":"25","author":"I Ertenli","year":"1998","unstructured":"Ertenli I, Kiraz S, Arici M, Haznedaroglu IC, Calg\u00fcneri M, Celik I, Kirazli S (1998) P-selectin as a circulating molecular marker in rheumatoid arthritis with thrombocytosis. J Rheumatol 25:1054\u20131058","journal-title":"J Rheumatol"},{"key":"1446_CR70","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.ijcard.2008.01.038","volume":"134","author":"GS Bhatia","year":"2009","unstructured":"Bhatia GS, Sosin MD, Patel JV, Grindulis KA, Khattak FH, Davis RC, Lip GY (2009) Plasma indices of endothelial and platelet activation in rheumatoid disease: relationship to cardiovascular co-morbidity. Int J Cardiol 134:97\u2013103","journal-title":"Int J Cardiol"},{"key":"1446_CR71","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/j.0300-9475.2004.01389.x","volume":"59","author":"A Ate\u015f","year":"2004","unstructured":"Ate\u015f A, Kinikli G, Turgay M, Duman M (2004) Serum-soluble selectin levels in patients with rheumatoid arthritis and systemic sclerosis. Scand J Immunol 59:315\u2013320","journal-title":"Scand J Immunol"},{"key":"1446_CR72","first-page":"2347","volume":"31","author":"A Bunescu","year":"2004","unstructured":"Bunescu A, Seideman P, Lenkei R, Levin K, Egberg N (2004) Enhanced Fcgamma receptor I, alphaMbeta2 integrin receptor expression by monocytes and neutrophils in rheumatoid arthritis: interaction with platelets. J Rheumatol 31:2347\u20132355","journal-title":"J Rheumatol"},{"key":"1446_CR73","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1080\/095371000403071","volume":"11","author":"IA Hagberg","year":"2000","unstructured":"Hagberg IA, Lyberg T (2000) Blood platelet activation evaluated by flow cytometry: optimised methods for clinical studies. Platelets 11:137\u2013150","journal-title":"Platelets"},{"key":"1446_CR74","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1055\/s-2005-916673","volume":"31","author":"U Klinkhardt","year":"2005","unstructured":"Klinkhardt U, Harder S (2005) Flow cytometric measurement of platelet-leukocyte aggregates: a possible target to monitor platelet function? Semin Thromb Hemost 31:400\u2013403","journal-title":"Semin Thromb Hemost"},{"key":"1446_CR75","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1046\/j.1365-2141.2001.03101.x","volume":"115","author":"JE Joseph","year":"2001","unstructured":"Joseph JE, Harrison P, Mackie IJ, Isenberg DA, Machin SJ (2001) Increased circulating platelet-leucocyte complexes and platelet activation in patients with antiphospholipid syndrome, systemic lupus erythematosus and rheumatoid arthritis. Br J Haematol 115:451\u2013459","journal-title":"Br J Haematol"},{"key":"1446_CR76","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1055\/s-2005-916672","volume":"31","author":"A Matzdorff","year":"2005","unstructured":"Matzdorff A (2005) Platelet function tests and flow cytometry to monitor antiplatelet therapy. Semin Thromb Hemost 31:393\u2013399","journal-title":"Semin Thromb Hemost"},{"key":"1446_CR77","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1007\/s10067-007-0550-0","volume":"26","author":"F Wang","year":"2007","unstructured":"Wang F, Wang NS, Yan CG, Li JH, Tang LQ (2007) The significance of platelet activation in rheumatoid arthritis. Clin Rheumatol 26:768\u2013771","journal-title":"Clin Rheumatol"},{"key":"1446_CR78","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0021-9150(99)00485-2","volume":"152","author":"FH Man de","year":"2000","unstructured":"de Man FH, Nieuwland R, van der Laarse A, Romijn F, Smelt AH, Gevers Leuven JA, Sturk A (2000) Activated platelets in patients with severe hypertriglyceridemia: effects of triglyceride-lowering therapy. Atherosclerosis 152:407\u2013414","journal-title":"Atherosclerosis"},{"key":"1446_CR79","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.atherosclerosis.2006.04.028","volume":"192","author":"RA Preston","year":"2007","unstructured":"Preston RA, Coffey JO, Materson BJ, Ledford M, Alonso AB (2007) Elevated platelet P-selectin expression and platelet activation in high risk patients with uncontrolled severe hypertension. Atherosclerosis 192:148\u2013154","journal-title":"Atherosclerosis"},{"key":"1446_CR80","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1080\/07853890802227089","volume":"41","author":"I Chung","year":"2009","unstructured":"Chung I, Choudhury A, Patel J, Lip GY (2009) Soluble, platelet-bound, and total P-selectin as indices of platelet activation in congestive heart failure. Ann Med 41:45\u201351","journal-title":"Ann Med"},{"key":"1446_CR81","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1161\/01.CIR.0000081765.88440.51","volume":"108","author":"H Koyama","year":"2003","unstructured":"Koyama H, Maeno T, Fukumoto S, Shoji T, Yamane T, Yokoyama H, Emoto M, Shoji T, Tahara H, Inaba M, Hino M, Shioi A, Miki T, Nishizawa Y (2003) Platelet P-selectin expression is associated with atherosclerotic wall thickness in carotid artery in humans. Circulation 108:524\u2013529","journal-title":"Circulation"},{"key":"1446_CR82","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1002\/art.10312","volume":"46","author":"EA Knijff-Dutmer","year":"2002","unstructured":"Knijff-Dutmer EA, Koerts J, Nieuwland R, Kalsbeek-Batenburg EM, van de Laar MA (2002) Elevated levels of platelet microparticles are associated with disease activity in rheumatoid arthritis. Arthritis Rheum 46:1498\u20131503","journal-title":"Arthritis Rheum"},{"key":"1446_CR83","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/j.1365-3083.2007.01984.x","volume":"66","author":"SP Ardoin","year":"2007","unstructured":"Ardoin SP, Shanahan JC, Pisetsky DS (2007) The role of microparticles in inflammation and thrombosis. Scand J Immunol 66:159\u2013165","journal-title":"Scand J Immunol"},{"key":"1446_CR84","doi-asserted-by":"crossref","first-page":"2857","DOI":"10.1002\/art.10587","volume":"46","author":"RJ Berckmans","year":"2002","unstructured":"Berckmans RJ, Nieuwland R, Tak PP, B\u00f6ing AN, Romijn FP, Kraan MC, Breedveld FC, Hack CE, Sturk A (2002) Cell-derived microparticles in synovial fluid from inflamed arthritic joints support coagulation exclusively via a factor VII-dependent mechanism. Arthritis Rheum 46:2857\u20132866","journal-title":"Arthritis Rheum"},{"key":"1446_CR85","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/35393","volume":"391","author":"V Henn","year":"1998","unstructured":"Henn V, Slupsky JR, Gr\u00e4fe M, Anagnostopoulos I, F\u00f6rster R, M\u00fcller-Berghaus G, Kroczek RA (1998) CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells. Nature 391:591\u2013594","journal-title":"Nature"},{"key":"1446_CR86","doi-asserted-by":"crossref","first-page":"2760","DOI":"10.1002\/(SICI)1521-4141(199809)28:09<2760::AID-IMMU2760>3.0.CO;2-N","volume":"28","author":"F Sallusto","year":"1998","unstructured":"Sallusto F, Schaerli P, Loetscher P, Schaniel C, Lenig D, Mackay CR, Qin S, Lanzavecchia A (1998) Rapid and coordinated switch in chemokine receptor expression during dendritic cell maturation. Eur J Immunol 28:2760\u20132769","journal-title":"Eur J Immunol"},{"key":"1446_CR87","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.coi.2004.09.012","volume":"16","author":"F Sallusto","year":"2004","unstructured":"Sallusto F, Mackay CR (2004) Chemoattractants and their receptors in homeostasis and inflammation. Curr Opin Immunol 16:724\u2013731","journal-title":"Curr Opin Immunol"},{"key":"1446_CR88","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1002\/art.22439","volume":"56","author":"KW Kim","year":"2007","unstructured":"Kim KW, Cho ML, Kim HR, Ju JH, Park MK, Oh HJ, Kim JS, Park SH, Lee SH, Kim HY (2007) Up-regulation of stromal cell-derived factor 1 (CXCL12) production in rheumatoid synovial fibroblasts through interactions with T lymphocytes: role of interleukin-17 and CD40L-CD40 interaction. Arthritis Rheum 56:1076\u20131086","journal-title":"Arthritis Rheum"},{"key":"1446_CR89","doi-asserted-by":"crossref","first-page":"3116","DOI":"10.4049\/jimmunol.163.6.3116","volume":"163","author":"D Kyburz","year":"1999","unstructured":"Kyburz D, Corr M, Brinson DC, Von Damm A, Tighe H, Carson DA (1999) Human rheumatoid factor production is dependent on CD40 signaling and autoantigen. J Immunol 163:3116\u20133122","journal-title":"J Immunol"},{"key":"1446_CR90","first-page":"2583","volume":"28","author":"N Tamura","year":"2001","unstructured":"Tamura N, Kobayashi S, Kato K, Bando H, Haruta K, Oyanagi M, Kuriyama M, Kipps TJ, Hashimoto H (2001) Soluble CD154 in rheumatoid arthritis: elevated plasma levels in cases with vasculitis. J Rheumatol 28:2583\u20132590","journal-title":"J Rheumatol"},{"key":"1446_CR91","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1080\/03009740510026607","volume":"34","author":"M McLaren","year":"2005","unstructured":"McLaren M, Waring A, Galarraga B, Rudd A, Morley K, Belch JJ (2005) Investigation of platelet glycoprotein IIIa polymorphism using flow cytometry in patients with rheumatoid arthritis. Scand J Rheumatol 34:437\u2013440","journal-title":"Scand J Rheumatol"},{"key":"1446_CR92","doi-asserted-by":"crossref","first-page":"R81","DOI":"10.1186\/ar1951","volume":"8","author":"M Jackson","year":"2006","unstructured":"Jackson M, Ahmad Y, Bruce IN, Coupes B, Brenchley PE (2006) Activation of transforming growth factor-beta1 and early atherosclerosis in systemic lupus erythematosus. Arthritis Res Ther 8:R81","journal-title":"Arthritis Res Ther"},{"key":"1446_CR93","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1002\/jcb.21360","volume":"102","author":"B Weicht","year":"2007","unstructured":"Weicht B, Maitz P, Kandler B, Fischer MB, Watzek G, Gruber R (2007) Activated platelets positively regulate RANKL-mediated osteoclast differentiation. J Cell Biochem 102:1300\u20131307","journal-title":"J Cell Biochem"},{"key":"1446_CR94","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1136\/ard.2004.031674","volume":"64","author":"DL Mattey","year":"2005","unstructured":"Mattey DL, Nixon N, Dawes PT, Kerr J (2005) Association of polymorphism in the transforming growth factor {beta}1 gene with disease outcome and mortality in rheumatoid arthritis. Ann Rheum Dis 64:1190\u20131194","journal-title":"Ann Rheum Dis"},{"key":"1446_CR95","doi-asserted-by":"crossref","first-page":"R151","DOI":"10.1186\/ar2045","volume":"8","author":"VP Halm van","year":"2006","unstructured":"van Halm VP, Nurmohamed MT, Twisk JW, Dijkmans BA, Voskuyl AE (2006) Disease-modifying antirheumatic drugs are associated with a reduced risk for cardiovascular disease in patients with rheumatoid arthritis: a case control study. Arthritis Res Ther 8:R151","journal-title":"Arthritis Res Ther"},{"key":"1446_CR96","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/S0140-6736(02)08213-2","volume":"359","author":"HK Choi","year":"2002","unstructured":"Choi HK, Hern\u00e1n MA, Seeger JD, Robins JM, Wolfe F (2002) Methotrexate and mortality in patients with rheumatoid arthritis: a prospective study. Lancet 359:1173\u20131177","journal-title":"Lancet"},{"key":"1446_CR97","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.jaut.2008.07.002","volume":"31","author":"F Ingegnoli","year":"2008","unstructured":"Ingegnoli F, Fantini F, Favalli EG, Soldi A, Griffini S, Galbiati V, Meroni PL, Cugno M (2008) Inflammatory and prothrombotic biomarkers in patients with rheumatoid arthritis: effects of tumor necrosis factor-alpha blockade. J Autoimmun 31:175\u2013179","journal-title":"J Autoimmun"},{"key":"1446_CR98","first-page":"311","volume":"26","author":"MA Gonzalez-Gay","year":"2008","unstructured":"Gonzalez-Gay MA, Garcia-Unzueta MT, Gonzalez-Juanatey C, Miranda-Filloy JA, Vazquez-Rodriguez TR, De Matias JM, Martin J, Dessein PH, Llorca J (2008) Anti-TNF-alpha therapy modulates resistin in patients with rheumatoid arthritis. Clin Exp Rheumatol 26:311\u2013316","journal-title":"Clin Exp Rheumatol"},{"key":"1446_CR99","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1136\/ard.2008.093153","volume":"68","author":"C Trocm\u00e9","year":"2009","unstructured":"Trocm\u00e9 C, Marotte H, Baillet A, Pallot-Prades B, Garin J, Grange L, Miossec P, Tebib J, Berger F, Nissen MJ, Juvin R, Morel F, Gaudin P (2009) Apolipoprotein A-I and platelet factor 4 are biomarkers for infliximab response in rheumatoid arthritis. Ann Rheum Dis 68:1328\u20131333","journal-title":"Ann Rheum Dis"},{"key":"1446_CR100","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1093\/rheumatology\/32.6.467","volume":"32","author":"C Astbury","year":"1993","unstructured":"Astbury C, Platt R, Dixon JS, Le Gallez P, Hill J, Bird HA (1993) Optimizing the assessment of disease activity during treatment with anti-rheumatoid drugs. Br J Rheumatol 32:467\u2013473","journal-title":"Br J Rheumatol"},{"key":"1446_CR101","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1080\/030097498442415","volume":"27","author":"DJ Veale","year":"1998","unstructured":"Veale DJ, Maple C, Kirk G, McLaren M, Belch JJ (1998) Soluble cell adhesion molecules\u2013P-selectin and ICAM-1, and disease activity in patients receiving sulphasalazine for active rheumatoid arthritis. Scand J Rheumatol 27:296\u2013299","journal-title":"Scand J Rheumatol"},{"key":"1446_CR102","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1055\/s-0037-1613033","volume":"87","author":"RG Espinola","year":"2002","unstructured":"Espinola RG, Pierangeli SS, Gharavi AE, Harris EN (2002) Hydroxychloroquine reverses platelet activation induced by human IgG antiphospholipid antibodies. Thromb Haemost 87:518\u2013522","journal-title":"Thromb Haemost"},{"key":"1446_CR103","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1093\/rheumatology\/kem311","volume":"47","author":"VF Panoulas","year":"2008","unstructured":"Panoulas VF, Douglas KM, Stavropoulos-Kalinoglou A, Metsios GS, Nightingale P, Kita MD, Elisaf MS, Kitas GD (2008) Long-term exposure to medium-dose glucocorticoid therapy associates with hypertension in patients with rheumatoid arthritis. Rheumatology (Oxford) 47:72\u201375","journal-title":"Rheumatology (Oxford)"},{"key":"1446_CR104","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1080\/09537100600759105","volume":"17","author":"P Maitz","year":"2006","unstructured":"Maitz P, Kandler B, Fischer MB, Watzek G, Gruber R (2006) Activated platelets retain their potential to induce osteoclast-like cell formation in murine bone marrow cultures. Platelets 17:477\u2013483","journal-title":"Platelets"},{"key":"1446_CR105","doi-asserted-by":"crossref","unstructured":"Gasparyan AY, Stavropoulos-Kalinoglou A, Toms TE, Douglas KM, Kitas GD (2010) Association of mean platelet volume with hypertension in rheumatoid arthritis. Inflamm Allergy Drug Targets 9:45\u201350","DOI":"10.2174\/187152810791292854"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-010-1446-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00296-010-1446-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-010-1446-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,31]],"date-time":"2023-05-31T15:44:38Z","timestamp":1685547878000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00296-010-1446-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,4,14]]},"references-count":105,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,2]]}},"alternative-id":["1446"],"URL":"https:\/\/doi.org\/10.1007\/s00296-010-1446-x","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,4,14]]}}}